Elsevier

Biological Psychiatry

Volume 89, Issue 1, 1 January 2021, Pages 20-31
Biological Psychiatry

Review
Pleiotropy and Cross-Disorder Genetics Among Psychiatric Disorders

https://doi.org/10.1016/j.biopsych.2020.09.026Get rights and content

Abstract

Genome-wide analyses of common and rare genetic variations have documented the heritability of major psychiatric disorders, established their highly polygenic genetic architecture, and identified hundreds of contributing variants. In recent years, these studies have illuminated another key feature of the genetic basis of psychiatric disorders: the important role and pervasive nature of pleiotropy. It is now clear that a substantial fraction of genetic influences on psychopathology transcend clinical diagnostic boundaries. In this review, we summarize evidence in psychiatry for pleiotropy at multiple levels of analysis: from overall genome-wide correlation to biological pathways and down to the level of individual loci. We examine underlying mechanisms of observed pleiotropy, including genetic effects on neurodevelopment, diverse actions of regulatory elements, mediated effects, and spurious associations of genomic variation with multiple phenotypes. We conclude with an exploration of the implications of pleiotropy for understanding the genetic basis of psychiatric disorders, informing nosology, and advancing the aims of precision psychiatry and genomic medicine.

Section snippets

Genetic Overlap and Pleiotropy in Psychiatry

Well before it became possible to interrogate the genome at the level of DNA variation itself, family and twin studies began documenting overlap among psychiatric disorders [see (1) and (5) for review]. In the past decade, characterizing such overlap at a molecular genetic level has become a major activity in the field of psychiatric genetics. The basis of this shared genetic vulnerability is generally attributed to the phenomenon of pleiotropy. However, pleiotropy can be considered at varying

Potential Mechanisms Underlying Shared Genetic Influences

The observation that a genetic variant is associated with multiple phenotypes can be due to a number of phenomena (2). In this section, we discuss potential mechanisms of observed pleiotropy that can drive shared genetic risk associations across complex traits (depicted in Figure 2).

Implications for Understanding the Genetic Basis of Psychiatric Disorders

We have learned that some genes and pathways may have pleiotropic effects on psychopathology by impacting neurodevelopment. For example, rare CNVs that have broad neuropsychiatric effects appear to disrupt neurodevelopment in fundamental ways that confer risk for multiple NDDs. Common variants with highly pleiotropic effects also appear to act in part by modulating neurodevelopmental processes and the establishment of brain circuitry that may create a relatively pluripotent vulnerability to

Implications for Psychiatric Nosology

The current systems for classifying psychiatric disorders (the ICD and DSM) have relied on the consensus of experts and historical traditions for grouping symptoms into syndromes. The evolving database of genetic relationships and pleiotropic genes reviewed here has revealed surprising degrees of shared biology among these syndromes. Incorporating these insights into our understanding of psychopathology encourages the possibility of constructing a more bottom-up classification of psychiatric

Implications for Genetic Counseling and Genomic Medicine

The pleiotropic nature of many genetic variations is also relevant for the implementation of genomic medicine. For example, a genomic work-up including chromosomal microarray analysis and exome sequencing has been recommended as standard of care for idiopathic ASD (104). As we have seen, however, many rare CNVs and mutations associated with ASD are also associated with other NDDs and with SCZ. The expanding database of pleiotropic associations may thus complicate genetic counseling for

Implications for Precision Psychiatry and Therapeutic Development

The emerging paradigm of precision medicine has been defined as “an approach to disease treatment and prevention that seeks to maximize effectiveness by taking into account individual variability in genes, environment, and lifestyle” (109). Several fields of medicine have already had success in this effort, with particular emphasis in two directions. First, genetic and genomic information has been used to guide the development of novel drug targets for cancers, hyperlipidemia, and cystic

Conclusions

Just as genetic studies have demonstrated that essentially all psychiatric disorders are heritable, research over the past decade has taught us that virtually all of these disorders have some degree of genetic overlap with other phenotypes. However, we are only beginning to understand the details of how these phenotypes are related, the molecular mechanisms of cross-phenotype correlations, and the implications of pleiotropy for precision and genomic medicine. Progress in this area will benefit

Acknowledgments and Disclosures

This work was supported by the National Institute of Mental Health (Grant No. R01 MH118233 [to JWS] and Grant Nos. NIMH R00 MH101367 and R01 MH119243 [to PHL]) and Demarest Lloyd, Jr. Foundation (to JWS).

JWS is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe and a member of the Leon Levy Foundation Neuroscience Advisory Board and received an honorarium for an internal seminar at Biogen, Inc. The other authors report no biomedical financial interests or

References (113)

  • B. Raj et al.

    Alternative splicing in the mammalian nervous system: Recent insights into mechanisms and functional roles

    Neuron

    (2015)
  • H. Kim et al.

    Disruption of neurexin 1 associated with autism spectrum disorder

    Am J Hum Genet

    (2008)
  • T. Serafini et al.

    Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system

    Cell

    (1996)
  • M. Gallagher et al.

    The post-GWAS era: From association to function

    Am J Hum Genet

    (2018)
  • T. Fukaya et al.

    Enhancer control of transcriptional bursting

    Cell

    (2016)
  • B.F. Voight et al.

    Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Lancet

    (2012)
  • J.W. Smoller

    Disorders and borders: Psychiatric genetics and nosology

    Am J Med Genet B Neuropsychiatr Genet

    (2013)
  • N. Solovieff et al.

    Pleiotropy in complex traits: Challenges and strategies

    Nat Rev Genet

    (2013)
  • D.M. Jordan et al.

    HOPS: A quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases

    Genome Biol

    (2019)
  • K. Watanabe et al.

    A global overview of pleiotropy and genetic architecture in complex traits

    Nat Genet

    (2019)
  • J.W. Smoller et al.

    Psychiatric genetics and the structure of psychopathology

    Mol Psychiatry

    (2019)
  • D.J. Schaid et al.

    From genome-wide associations to candidate causal variants by statistical fine-mapping

    Nat Rev Genet

    (2018)
  • W. van Rheenen et al.

    Genetic correlations of polygenic disease traits: from theory to practice

    Nat Rev Genet

    (2019)
  • O. Frei et al.

    Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation

    Nat Commun

    (2019)
  • Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis

    Lancet

    (2013)
  • M.J. Gandal et al.

    Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap

    Science

    (2018)
  • V. Anttila et al.

    Analysis of shared heritability in common disorders of the brain

    Science

    (2018)
  • Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

    Cell

    (2019)
  • A.D. Grotzinger et al.

    Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits

    Nat Hum Behav

    (2019)
  • H.J. Watson et al.

    Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa

    Nat Genet

    (2019)
  • J.G. Pouget et al.

    Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk

    Hum Mol Genet

    (2019)
  • S. Wassertheil-Smoller et al.

    Polygenic risk for depression increases risk of ischemic stroke: From the Stroke Genetics Network Study

    Stroke

    (2018)
  • J. Dennis et al.

    Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease

    Mol Psychiatry

    (2019)
  • Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

    Nat Neurosci

    (2015)
  • S.E. Ellis et al.

    Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia

    Transl Psychiatry

    (2016)
  • J. Guan et al.

    Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder

    Transl Psychiatry

    (2019)
  • C.R. Marshall et al.

    Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Nat Genet

    (2017)
  • A.Y. Huang et al.

    Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome

    Neuron

    (2017)
  • M. Zarrei et al.

    A large data resource of genomic copy number variation across neurodevelopmental disorders

    NPJ Genom Med

    (2019)
  • D. Sun et al.

    Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size

    Mol Psychiatry

    (2020)
  • C.R.K. Ching et al.

    Mapping subcortical brain alterations in 22q11.2 deletion syndrome: Effects of deletion size and convergence with idiopathic neuropsychiatric illness

    Am J Psychiatry

    (2020)
  • Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Nat Genet

    (2017)
  • Y. Liu et al.

    Structural basis for Draxin-modulated axon guidance and fasciculation by Netrin-1 through DCC

    Neuron

    (2018)
  • D.E. Vosberg et al.

    Mesocorticolimbic connectivity and volumetric alterations in DCC mutation carriers

    J Neurosci

    (2018)
  • Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes

    Cell

    (2018)
  • Z. Zhu et al.

    Causal associations between risk factors and common diseases inferred from GWAS summary data

    Nat Commun

    (2018)
  • E.M. Byrne et al.

    Conditional GWAS analysis identifies putative disorder–specific SNPs for psychiatric disorders [published online ahead of print May 12]

    Mol Psychiatry.

    (2020)
  • W.J. Peyrot et al.

    Identifying loci with different allele frequencies among cases of eight psychiatric disorders using CC-GWAS

    bioRxiv

    (2020)
  • A.F. Pardiñas et al.

    Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

    Nat Genet

    (2018)
  • E. Stahl et al.

    Genome-wide association study identifies 30 loci associated with bipolar disorder

    Nat Genet

    (2019)
  • Cited by (63)

    • Systematic Review and Meta-Analysis: Risks of Anxiety Disorders in Offspring of Parents With Mood Disorders

      2024, Journal of the American Academy of Child and Adolescent Psychiatry
    • The Search for Unitary Mechanisms in Psychiatric Illness

      2023, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
    View all citing articles on Scopus
    View full text